CCO Expert Recap

Update on Hepatitis B Management

Source: CCO Independent Conference Coverage of the 2008 Annual Meeting of the European Association for the Study of the Liver*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update on Hepatitis B Management

Faculty:

Daniel Shouval, MD

CREDIT INFORMATION

Release Date: June 18, 2008

Expiration Date: June 17, 2009

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the efficacy of peginterferon alfa or nucleos(t)ides in treatment-naive, HBV-infected patients
Discuss the safety and efficacy of changing treatment of HBV patients with suboptimal response to their initial nucleos(t)ide regimens
Recount strategies and outcomes for transplantation and hepatocellular carcinoma in the setting of HBV infection

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.